Tailored biological treatment for patients with moderate-to-severe psoriasis.
Martina MaurelliPaolo GisondiGiampiero GirolomoniPublished in: Expert review of clinical immunology (2022)
The presence of comorbidities, which may benefit from or contraindicate a given biologic, is the main driver of a tailored therapy. A personalized treatment associates maximum efficacy and minimal risk of side effects. In addition, there is the possibility of modifying disease-course inducing long-term remission and preventing the development of psoriatic arthritis.